Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 142


Impulsive Behaviors in Patients With Pathological Buying.

Zander H, Claes L, Voth EM, de Zwaan M, Müller A.

J Behav Addict. 2016 Sep;5(3):457-64. doi: 10.1556/2006.5.2016.050. Epub 2016 Jul 14.


Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.

Gebauer F, Gelis S, Zander H, Meyer KF, Wolters-Eisfeld G, Izbicki JR, Bockhorn M, Tachezy M.

Oncotarget. 2016 Apr 12;7(15):20945-52. doi: 10.18632/oncotarget.7976.


Acid-coated Textiles (pH 5.5-6.5)--a New Therapeutic Strategy for Atopic Eczema?

Jaeger T, Rothmaier M, Zander H, Ring J, Gutermuth J, Anliker MD.

Acta Derm Venereol. 2015 Jul;95(6):659-63. doi: 10.2340/00015555-1916.


Activated leukocyte cell adhesion molecule (CD166): an "inert" cancer stem cell marker for non-small cell lung cancer?

Tachezy M, Zander H, Wolters-Eisfeld G, Müller J, Wicklein D, Gebauer F, Izbicki JR, Bockhorn M.

Stem Cells. 2014 Jun;32(6):1429-36. doi: 10.1002/stem.1665.


CXCR7 expression in esophageal cancer.

Tachezy M, Zander H, Gebauer F, von Loga K, Pantel K, Izbicki JR, Bockhorn M.

J Transl Med. 2013 Sep 30;11:238. doi: 10.1186/1479-5876-11-238.


ALCAM (CD166) expression and serum levels in pancreatic cancer.

Tachezy M, Zander H, Marx AH, Stahl PR, Gebauer F, Izbicki JR, Bockhorn M.

PLoS One. 2012;7(6):e39018. doi: 10.1371/journal.pone.0039018. Epub 2012 Jun 20.


Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.

Witzel I, Schröder C, Müller V, Zander H, Tachezy M, Ihnen M, Jänicke F, Milde-Langosch K.

Oncology. 2012;82(6):305-12. doi: 10.1159/000337222. Epub 2012 May 3.


Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.

Tachezy M, Zander H, Gebauer F, Marx A, Kaifi JT, Izbicki JR, Bockhorn M.

J Surg Res. 2012 Sep;177(1):e15-20. doi: 10.1016/j.jss.2012.02.013. Epub 2012 Mar 30.


Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.

Ihnen M, Kress K, Kersten JF, Kilic E, Choschzick M, Zander H, Müller V, Mahner S, Jänicke F, Woelber L, Milde-Langosch K.

BMC Cancer. 2012 Apr 4;12:140. doi: 10.1186/1471-2407-12-140.


ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients.

Tachezy M, Effenberger K, Zander H, Minner S, Gebauer F, Vashist YK, Sauter G, Pantel K, Izbicki JR, Bockhorn M.

Int J Cancer. 2012 Jul 15;131(2):396-405. doi: 10.1002/ijc.26377. Epub 2011 Oct 20.


ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients.

Tachezy M, Zander H, Marx AH, Gebauer F, Rawnaq T, Kaifi JT, Sauter G, Izbicki JR, Bockhorn M.

J Surg Res. 2011 Oct;170(2):226-32. doi: 10.1016/j.jss.2011.06.002. Epub 2011 Jul 2.


Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer.

Güngör C, Zander H, Effenberger KE, Vashist YK, Kalinina T, Izbicki JR, Yekebas E, Bockhorn M.

Cancer Res. 2011 Jul 15;71(14):5009-19. doi: 10.1158/0008-5472.CAN-11-0036. Epub 2011 Jun 1.


Circulating levels of cell adhesion molecule L1 as a prognostic marker in gastrointestinal stromal tumor patients.

Zander H, Rawnaq T, von Wedemeyer M, Tachezy M, Kunkel M, Wolters G, Bockhorn M, Schachner M, Izbicki JR, Kaifi J.

BMC Cancer. 2011 May 22;11:189:1-7. doi: 10.1186/1471-2407-11-189.


Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.

Gebauer F, Tachezy M, Effenberger K, von Loga K, Zander H, Marx A, Kaifi JT, Sauter G, Izbicki JR, Bockhorn M.

J Surg Oncol. 2011 Aug 1;104(2):140-5. doi: 10.1002/jso.21957. Epub 2011 Apr 25.


L1 is highly expressed in tumors of the nervous system: a study of over 8000 human tissues.

Rawnaq T, Quaas A, Zander H, Gros SJ, Reichelt U, Blessmann M, Wilzcak W, Schachner M, Sauter G, Izbicki JR, Kaifi JT.

J Surg Res. 2012 Apr;173(2):314-9. doi: 10.1016/j.jss.2010.10.029. Epub 2010 Nov 21.


Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors.

Rawnaq T, Kunkel M, Bachmann K, Simon R, Zander H, Brandl S, Sauter G, Izbicki JR, Kaifi JT.

Ann Surg Oncol. 2011 Feb;18(2):559-65. doi: 10.1245/s10434-010-1191-0. Epub 2010 Jun 30.


Biochemical characterization of the recombinant human Nogo-A ectodomain.

Zander H, Hettich E, Greiff K, Chatwell L, Skerra A.

FEBS J. 2007 May;274(10):2603-13. Epub 2007 Apr 16.


The healing of phenolized pulp exposures. 1949.

Zander HA, Glass RL.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Aug;100(2 Suppl):S97-101. No abstract available.


Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.

Breithaupt C, Schubart A, Zander H, Skerra A, Huber R, Linington C, Jacob U.

Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9446-51. Epub 2003 Jul 21.

Supplemental Content

Loading ...
Support Center